What cyclobenzaprine dose is equivalent to tizanidine 4 mg in an adult?

No Direct Dose Equivalency Exists Between Tizanidine and Cyclobenzaprine

There is no established equivalent dose conversion between tizanidine 4 mg and cyclobenzaprine because these medications have fundamentally different mechanisms of action, pharmacokinetics, and are not interchangeable.

Why These Medications Cannot Be Directly Converted

Different Mechanisms of Action

Tizanidine is an α2-adrenergic receptor agonist (a clonidine derivative) that acts centrally as a spasmolytic agent 1. Cyclobenzaprine is a centrally acting 5-HT2 receptor antagonist structurally related to amitriptyline 1. These distinct mechanisms mean they cannot be dose-converted like medications within the same class.

Standard Dosing for Each Medication

Tizanidine dosing:

• Starting dose: 2 mg up to three times daily 2
• Typical dose: 4 mg (as referenced in your question) 3

Cyclobenzaprine dosing:

• Starting dose: 5 mg three times daily 4
• May increase to 10 mg three times daily based on response 4

Clinical Considerations When Switching

Comparative Efficacy Data

A head-to-head trial found no significant differences between tizanidine 4 mg and cyclobenzaprine 10 mg for myofascial jaw pain when added to self-care management 5. However, this single study in a specific pain condition cannot establish dose equivalency.

Recent evidence shows that among skeletal muscle relaxants for acute low back pain, there were no statistically significant differences in efficacy between tizanidine, cyclobenzaprine, and other muscle relaxants—all performed similarly to placebo when combined with NSAIDs 6.

Safety Profile Differences

Critical safety distinction: Tizanidine carries higher risks than cyclobenzaprine in older adults:

• 69% greater risk of composite injury outcomes with baclofen vs. cyclobenzaprine 7
• 34% greater risk with tizanidine vs. cyclobenzaprine 7
• Baclofen shows 54% greater injury risk and 3.33-fold higher delirium risk compared to tizanidine 8

Tizanidine-specific concerns:

• Dose-dependent sedation, drowsiness, dizziness, ataxia 1
• Significant hypotension and bradycardia risk, especially with CYP1A2 inhibitors 1, 9
• 50% reduced clearance in women taking oral contraceptives 3
• Requires slow taper to avoid withdrawal (rebound tachycardia, hypertension, hypertonia) 1

Cyclobenzaprine-specific concerns:

• Anticholinergic effects (confusion, urinary retention, dry mouth) 1
• Withdrawal symptoms (malaise, nausea, headache) are uncomfortable but not life-threatening 1
• More adverse medication effects than placebo in ED studies 6

Practical Approach to Switching

If switching from tizanidine 4 mg to cyclobenzaprine:

1. Do not abruptly stop tizanidine - taper slowly to avoid withdrawal 1

2. Start cyclobenzaprine at standard initial dosing:

   • Begin with 5 mg three times daily 4
   • May increase to 10 mg three times daily if needed 4

3. Monitor for different adverse effect profiles:

   • Watch for anticholinergic effects with cyclobenzaprine
   • Expect less hypotension/bradycardia risk than with tizanidine

4. Consider that neither medication has strong evidence for chronic pain 10. Guidelines note that muscle relaxants including cyclobenzaprine "do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain" 10.

Important Caveats

• Both medications are recommended for acute musculoskeletal pain only (2-3 weeks maximum) 11
• Neither should be first-line for chronic pain management 10
• In older adults, consider avoiding both medications given injury risks 7, 8
• The question of "equivalent dose" is clinically inappropriate—these are distinct medications requiring independent dosing decisions based on standard prescribing guidelines